Comparison of Tocilizumab and Convalescent Plasma Therapy for COVID-19: A Systematic Review: OAJBS Publishers
Background:
The current pandemic referred to as coronavirus disease 2019 (COVID-19), has
identified the causative respiratory pathogen as severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2). High viral load leads to cytokine storm
(CS) and other symptoms that leads to severity, mortality and infectivity of
patients. Methods: A review of databases PubMed and Google Scholar was
conducted from May 25 to June 16, 2020. After exclusion of systematic reviews,
studies on other treatment strategies, meta-analysis and articles not related
to COVID-19 treatment, 21 clinical studies on COVID-19 infection of tocilizumab
(TCZ) and convalescent plasma (CP) were identified and included.
https://biomedscis.com/fulltext/comparison-of-tocilizumab-and-convalescent-plasma-therapy-for-covid-19-a-systematic-review.ID.000215.php
To
Know More About Open Access Journal of
Biomedical Science Please Visit: Biomedscis
Are
Click On: https://Biomedscis.Com/
Comments
Post a Comment